JP2017537605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537605A5 JP2017537605A5 JP2017517300A JP2017517300A JP2017537605A5 JP 2017537605 A5 JP2017537605 A5 JP 2017537605A5 JP 2017517300 A JP2017517300 A JP 2017517300A JP 2017517300 A JP2017517300 A JP 2017517300A JP 2017537605 A5 JP2017537605 A5 JP 2017537605A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- amino acid
- biologically active
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462058945P | 2014-10-02 | 2014-10-02 | |
| US62/058,945 | 2014-10-02 | ||
| PCT/US2015/053393 WO2016054312A1 (en) | 2014-10-02 | 2015-10-01 | Influenza a virus variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537605A JP2017537605A (ja) | 2017-12-21 |
| JP2017537605A5 true JP2017537605A5 (enExample) | 2018-11-08 |
| JP6953307B2 JP6953307B2 (ja) | 2021-10-27 |
Family
ID=54293399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517300A Expired - Fee Related JP6953307B2 (ja) | 2014-10-02 | 2015-10-01 | インフルエンザａ型ウイルスバリアント |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10801077B2 (enExample) |
| EP (1) | EP3201221A1 (enExample) |
| JP (1) | JP6953307B2 (enExample) |
| CN (1) | CN107002052B (enExample) |
| CA (1) | CA2963076A1 (enExample) |
| MA (1) | MA40773A (enExample) |
| WO (1) | WO2016054312A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20207129B (en) | 2009-06-17 | 2020-07-10 | Vertex Pharma | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| PT3068776T (pt) | 2013-11-13 | 2019-08-26 | Vertex Pharma | Inibidores da replicação de vírus da gripe |
| HUE038820T2 (hu) | 2013-11-13 | 2018-11-28 | Vertex Pharma | Eljárás influenzavírusok replikációjának inhibitorai elõállítására |
| MA40772A (fr) * | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus de la grippe a |
| WO2016183120A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| EP3294717B1 (en) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Methods of preparing inhibitors of influenza viruses replication |
| CN106929482A (zh) * | 2015-12-31 | 2017-07-07 | 北京大学 | 定点突变的流感病毒、其活疫苗及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843701A (en) | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| EP1477561B1 (en) | 1996-10-17 | 2008-12-10 | Mitsubishi Chemical Corporation | Molecule assigning genotype to phenotype and use thereof |
| IL131016A (en) | 1997-01-21 | 2004-12-15 | Gen Hospital Corp | Selection of proteins using RNA-protein blends |
| AU5921101A (en) * | 2000-04-28 | 2001-11-12 | St Jude Childrens Res Hospital | Dna transfection system for the generation of infectious influenza virus |
| CA2456292A1 (en) | 2001-08-14 | 2003-02-27 | Toyama Chemical Co., Ltd. | Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog |
| ES2364340T3 (es) | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| WO2006050076A1 (en) | 2004-10-29 | 2006-05-11 | Janssen Pharmaceutica, N.V. | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| FI20060200A0 (fi) | 2005-04-20 | 2006-02-27 | Glykos Finland Oy | Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi |
| AU2006247322A1 (en) | 2005-05-16 | 2006-11-23 | Irm Llc | Pyrrolopyridine derivatives as protein kinase inhibitors |
| KR20080047355A (ko) * | 2005-07-06 | 2008-05-28 | 바이오칩 이노베이션즈 피티와이 리미티드 | 표적 핵산 서열 분석 방법 및 키트 |
| KR100708593B1 (ko) | 2006-03-23 | 2007-04-18 | 주식회사 고려비엔피 | 발육란 생산성이 우수한 저병원성 ｈ９ｎ２ 아형 조류인플루엔자 바이러스 |
| WO2009125395A1 (en) * | 2008-04-09 | 2009-10-15 | Technion Research & Development Foundation Ltd. | Anti influenza antibodies and uses thereof |
| GEP20207129B (en) | 2009-06-17 | 2020-07-10 | Vertex Pharma | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) * | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| MA40772A (fr) * | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus de la grippe a |
| WO2016183120A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
-
2015
- 2015-09-30 MA MA040773A patent/MA40773A/fr unknown
- 2015-10-01 JP JP2017517300A patent/JP6953307B2/ja not_active Expired - Fee Related
- 2015-10-01 CA CA2963076A patent/CA2963076A1/en not_active Abandoned
- 2015-10-01 CN CN201580063468.8A patent/CN107002052B/zh not_active Expired - Fee Related
- 2015-10-01 WO PCT/US2015/053393 patent/WO2016054312A1/en not_active Ceased
- 2015-10-01 EP EP15779136.9A patent/EP3201221A1/en not_active Withdrawn
-
2017
- 2017-03-31 US US15/475,326 patent/US10801077B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017536804A5 (enExample) | ||
| Álvarez-Buylla et al. | Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? | |
| Okomo‐Adhiambo et al. | Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors | |
| US20140005070A1 (en) | Markers associated with cyclin-dependent kinase inhibitors | |
| EP2630239B1 (en) | Kit for detecting bovine leukemia virus (blv), and use thereof | |
| RU2017114675A (ru) | Варианты вируса гриппа a | |
| KR20170015509A (ko) | 담도암 검출 키트 또는 디바이스 및 검출 방법 | |
| Jagielski et al. | Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates | |
| Zhan et al. | Evolution of methicillin-resistant Staphylococcus aureus: Evidence of positive selection in a penicillin-binding protein (PBP) 2a coding gene mecA | |
| JP7855586B2 (ja) | コロナウイルス感染症を発症するリスクが高い対象を特定する方法及びその治療法 | |
| Huang et al. | Development of a PCR assay for diagnosis of Pneumocystis carinii pneumonia based on amplification of the multicopy major surface glycoprotein gene family | |
| Cotroneo et al. | Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants | |
| WO2016042114A1 (en) | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis | |
| JP7084034B2 (ja) | 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法 | |
| US20200216903A1 (en) | Mitochondrial Disease Genetic Diagnostics | |
| CN104313123B (zh) | 一种结核分枝杆菌四种一线药物耐药基因特异片段组合及其应用 | |
| CN103540676B (zh) | 一种检测线粒体基因1555位a-g与1494位c-t突变的试剂盒 | |
| JPWO2020032228A5 (enExample) | ||
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| RU2009131072A (ru) | Диагностический маркер и базис для конструирования лекарственных средств при инфаркте миокарда и сердечной недостаточности | |
| Doumayrou et al. | Mapping genetic determinants of viral traits with FST and quantitative trait locus (QTL) approaches | |
| CN103555837B (zh) | 人ror2基因突变及其用途 | |
| CN102925555A (zh) | 定性检测人类braf v600e基因突变的测序引物对及其试剂盒 | |
| CN105316350B (zh) | 结核分枝杆菌EmbB突变基因及其用途 | |
| KR102942138B1 (ko) | 류마티스 관절염 환자에서 TNF-α 저해제 치료에 따른 피부 부작용 위험 예측용 다형성 마커 및 이를 이용한 류마티스 관절염 환자에서 TNF-α 저해제 치료에 따른 피부 부작용 위험 예측 방법 |